The mutational status of SF3B1 is an essential predictor of the presence of ring sideroblast (RS) in the bone marrow (6), occurring in more than 90% of patients with MDS with ring sideroblasts (MDS-RS) ≥5% (7). This evidence concerns the gene SF3B1 and myelodysplastic syndrome.